Role of quantitative hepatitis B surface antibodies in preventing hepatitis B virus-related hepatitis in patients treated with rituximab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Role of quantitative hepatitis B surface antibodies in preventing hepatitis B virus-related hepatitis in patients treated with rituximab

Published:2021-07-29 Issue:12 Volume:62 Page:2899-2906
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Pei Sung-Nan¹²³,Liu Yan-Fang⁴,Kuo Chin-Yuan¹,Wang Ming-Chung¹,Ma Ming-Chun¹,Liao Chun-Kai¹,Ng Hwee-Yeong¹,Chen Chien-Hung¹⁵

Affiliation:

1. Department of Internal Medicine, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung, Taiwan

2. Department of Hematology Oncology, E-Da Cancer Hospital, Kaohsiung, Taiwan

3. College of Medicine, I-Shou University, Kaohsiung, Taiwan

4. Global Epidemiology, Janssen Research & Development, Singapore, Singapore

5. College of Medicine, Chang Gung University, Taoyuan, Taiwan

Funder

Chang Gung Memorial Hospital

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2021.1948034

Reference21 articles.

1. Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: A prospective study

2. Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B

3. Hepatitis B Reactivation in Patients With Previous Hepatitis B Virus Exposure Undergoing Rituximab-Containing Chemotherapy for Lymphoma: A Prospective Study

4. Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study

5. Risk and prophylaxis strategy of hepatitis B virus reactivation in patients with lymphoma undergoing chemotherapy with or without rituximab

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidences of new hepatitis B infection and anti‐hepatitis B core‐negative occult hepatitis B infection among Japanese blood donors in relation to anti‐hepatitis B surface antigen levels;Journal of Medical Virology;2024-07

2. Stratified management based on surface antibody for the prevention of hepatitis B virus reactivation in lymphoma patients;British Journal of Haematology;2023-10-06

3. HBsAg (−)/HBsAb (−)/HBeAg (−)/HBeAb (+)/HBcAb (+) predicts a high risk of hepatitis B reactivation in patients with B‐cell lymphoma receiving rituximab based immunochemotherapy;Journal of Medical Virology;2023-02

4. Multiple drugs;Reactions Weekly;2023-01-07

5. Cost-effectiveness of managing HBV reactivation in patients with resolved HBV infection treated with anti-CD20 antibody for B-cell non-Hodgkin lymphoma;Scientific Reports;2022-05-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3